SCHEMBL4849367

SCHEMBL4849367

CCC1(CC)CCC(c2cc(N3CCCC(OC)C3)ccc2N2CCNCC2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 3/20 0.36
CHRNB2 P17787 2/20 0.32
CHRNA4 P43681 2/20 0.32
HTR3E A5X5Y0 1/20 0.32
HTR3B O95264 1/20 0.32
HTR3A P46098 1/20 0.32
HTR3D Q70Z44 1/20 0.32
HTR3C Q8WXA8 1/20 0.32
NTSR1 P30989 3/20 0.32
HTR1A P08908 2/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
PDE7A Q13946 2/20 0.31
MAPT P10636 3/20 0.31
ALDH1A1 P00352 2/20 0.31
LRRK2 Q5S007 1/20 0.31
HTR1D P28221 1/20 0.31
HTR1B P28222 1/20 0.31
ADRB1 P08588 2/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849357 1.00 IDH1 (0.36) IDH1CHRNB2CHRNA4HTR3EHTR3B
SCHEMBL4857661 0.94 NTSR1 (0.36) IDH1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4857671 0.94 NTSR1 (0.36) IDH1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5015848 0.89 IDH1 (0.37) IDH1CHRNB2CHRNA4HTR3EHTR3B
SCHEMBL5015846 0.89 IDH1 (0.37) IDH1CHRNB2CHRNA4HTR3EHTR3B
SCHEMBL4857459 0.88 ADRB1 (0.36) IDH1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4852535 0.86 IDH1 (0.34) IDH1NTSR1
SCHEMBL4852545 0.86 IDH1 (0.34) IDH1NTSR1
Hydrochloric Acid SCHEMBL4857620 0.85 IDH1 (0.34) IDH1NTSR1
Hydrochloric Acid SCHEMBL4851030 0.85 IDH1 (0.34) IDH1NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1698620-B1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS EISAI R&D MAN CO LTD (JP) 2016-09-28 EP disclosed
US-7425554-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-09-16 US disclosed
US-7410971-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-08-12 US disclosed
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-17 US disclosed
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-12-07 US disclosed
EP-1698620-A1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS Eisai Co., Ltd. (JP) 2006-09-06 EP disclosed
US-20050261291-A1 1,2-Di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds CCR10, HRH3, HRH1 IDH1 3127/4885CHRNB2 544/4885CHRNA4 738/4885
US-20050261291-A1 1,2-Di(cyclic)substituted benzene compounds CCR10, HRH3, HRH2 IDH1 3104/4885CHRNB2 453/4885CHRNA4 592/4885
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds HRH3, CCR10, HRH1 IDH1 2256/4885CHRNB2 377/4885CHRNA4 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.